Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susumu Ogawa

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Annual Review of Physical Chemistry|April 25, 2002
Surface femtochemistry: observation and quantum control of frustrated desorption of alkali atoms from noble metalsHrvoje Petek, Susumu Ogawa
International Journal of Environmental Research and Public Health|August 7, 2015
Effects of Meteorological Conditions on PM2.5 Concentrations in Nagasaki, JapanJianhua Wang, Susumu Ogawa
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Plasma BNP levels in the treatment of type 2 diabetes with pioglitazoneSusumu Ogawa, Kazuhisa Takeuchi, Sadayoshi Ito
Endocrinology, Diabetes & Metabolism|March 1, 2019
Effects of sodium-glucose cotransporter 2 inhibitors on hypoglycaemia in brittle diabetic patients with decreased endogenous insulin secretionSusumu Ogawa, Kazuhiro Nako, Sadayoshi Ito
BMJ Open Diabetes Research & Care|July 10, 2015
Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetesSusumu Ogawa, Kazuhiro Nako, Masashi Okamura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 22, 2008
Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathySusumu Ogawa, Takefumi Mori, Kazuhiro Nako, et al.
Clinical and Experimental Pharmacology & Physiology|December 14, 2011
Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetesTakefumi Mori, Susumu Ogawa, Allen W Cowely, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2008
Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetesSusumu Ogawa, Takefumi Mori, Kazuhiro Nako, et al.
Clinical and Experimental Pharmacology & Physiology|May 17, 2006
Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitorSusumu Ogawa, Kazuhisa Takeuchi, Takefumi Mori, et al.
Journal of Exercise Science and Fitness|July 26, 2021
Effects of an unsupervised Nordic walking intervention on cognitive and physical function among older women engaging in volunteer activityYuta Nemoto, Ryota Sakurai, Susumu Ogawa, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Annual Review of Physical Chemistry|April 25, 2002
Surface femtochemistry: observation and quantum control of frustrated desorption of alkali atoms from noble metalsHrvoje Petek, Susumu Ogawa
International Journal of Environmental Research and Public Health|August 7, 2015
Effects of Meteorological Conditions on PM2.5 Concentrations in Nagasaki, JapanJianhua Wang, Susumu Ogawa
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Plasma BNP levels in the treatment of type 2 diabetes with pioglitazoneSusumu Ogawa, Kazuhisa Takeuchi, Sadayoshi Ito
Endocrinology, Diabetes & Metabolism|March 1, 2019
Effects of sodium-glucose cotransporter 2 inhibitors on hypoglycaemia in brittle diabetic patients with decreased endogenous insulin secretionSusumu Ogawa, Kazuhiro Nako, Sadayoshi Ito
BMJ Open Diabetes Research & Care|July 10, 2015
Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetesSusumu Ogawa, Kazuhiro Nako, Masashi Okamura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 22, 2008
Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathySusumu Ogawa, Takefumi Mori, Kazuhiro Nako, et al.
Clinical and Experimental Pharmacology & Physiology|December 14, 2011
Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetesTakefumi Mori, Susumu Ogawa, Allen W Cowely, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2008
Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetesSusumu Ogawa, Takefumi Mori, Kazuhiro Nako, et al.
Clinical and Experimental Pharmacology & Physiology|May 17, 2006
Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitorSusumu Ogawa, Kazuhisa Takeuchi, Takefumi Mori, et al.
Journal of Exercise Science and Fitness|July 26, 2021
Effects of an unsupervised Nordic walking intervention on cognitive and physical function among older women engaging in volunteer activityYuta Nemoto, Ryota Sakurai, Susumu Ogawa, et al.
Pageof 10